Trial Profile
3-D Visualization of the Anti-Obstructive Effect of Levocetirizine - A Monocentric Clinical Trail With One Patient (Phase-IV-Study).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jun 2011
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary)
- Indications Allergic rhinitis
- Focus Pharmacodynamics
- Acronyms LevoNasalFlo
- 21 Jun 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2011 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 New trial record